Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 12 von 118

Details

Autor(en) / Beteiligte
Titel
Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation
Ist Teil von
  • Leukemia, 2010-10, Vol.24 (10), p.1742-1750
Ort / Verlag
London: Nature Publishing Group UK
Erscheinungsjahr
2010
Quelle
MEDLINE
Beschreibungen/Notizen
  • We sought to understand the genesis of the t(9;22) by characterizing genomic breakpoints in chronic myeloid leukemia (CML) and BCR–ABL -positive acute lymphoblastic leukemia (ALL). BCR–ABL breakpoints were identified in p190 ALL ( n =25), p210 ALL ( n =25) and p210 CML ( n =32); reciprocal breakpoints were identified in 54 cases. No evidence for significant clustering and no association with sequence motifs was found except for a breakpoint deficit in repeat regions within BCR for p210 cases. Comparison of reciprocal breakpoints, however, showed differences in the patterns of deletion/insertions between p190 and p210. To explore the possibility that recombinase-activating gene (RAG) activity might be involved in ALL, we performed extra-chromosomal recombination assays for cases with breakpoints close to potential cryptic recombination signal sequence (cRSS) sites. Of 13 ALL cases tested, 1/10 with p190 and 1/3 with p210 precisely recapitulated the forward BCR–ABL breakpoint and 1/10 with p190 precisely recapitulated the reciprocal breakpoint. In contrast, neither of the p210 CMLs tested showed functional cRSSs. Thus, although the t(9;22) does not arise from aberrant variable (V), joining (J) and diversity (D) (V(D)J) recombination, our data suggest that in a subset of ALL cases RAG might create one of the initiating double-strand breaks.
Sprache
Englisch
Identifikatoren
ISSN: 0887-6924
eISSN: 1476-5551
DOI: 10.1038/leu.2010.174
Titel-ID: cdi_hal_primary_oai_HAL_hal_00611097v1
Format
Schlagworte
631/208/191, 631/337/1427/2122, 692/699/67/1990/283/1896, 692/699/67/1990/283/2125, Acute lymphoblastic leukemia, Antigens, Base Sequence, BCR protein, Biological and medical sciences, Breakpoints, Cancer, Cancer Research, Cell division, Chromosome aberrations, Chromosome Breakpoints, Chromosomes, Chromosomes, Human, Pair 22, Chromosomes, Human, Pair 22 - genetics, Chromosomes, Human, Pair 9, Chromosomes, Human, Pair 9 - genetics, Chronic myeloid leukemia, Clustering, Critical Care Medicine, Fusion Proteins, bcr-abl, Fusion Proteins, bcr-abl - genetics, Genes, Genetic aspects, Genome, Human, Genome, Human - genetics, Genomic analysis, Hematologic and hematopoietic diseases, Hematology, Homeodomain Proteins, Homeodomain Proteins - genetics, Humans, Immunology, Intensive, Internal Medicine, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics, Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology, Life Sciences, Lymphatic leukemia, Medical genetics, Medical sciences, Medicine, Medicine & Public Health, Molecular Sequence Data, Myeloid leukemia, Oncology, original-article, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology, Prognosis, Proteins, Recombinase, Regions, Risk factors, Sequence Homology, Nucleic Acid, Stem cells, Translocation (Genetics), Translocation, Genetic, V(D)J recombination

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX